Tạp chí Tim mạch học Việt Nam
This review presents an overview of pharmacogenomics and pharmacogenetics in clinical practice (PGx) to pharmacogenomics in lipid-lowering therapies. Statins are the first-line choice in Lipid-lowering therapy to reduce...
Elevated lipoprotein(a) [Lp(a)] is an causal risk factor for atherosclerosis and is hereditary, which requires attention, because there is no approved medication formally for Lp(a) lowering in clinical pratice; even stat...
Current guidelines emphasize the prevention of cardiovascular disease through lifestyle interventions and lipid-lowering therapies. Specifically, treatment goals for LDL-C reduction tend to be more stringent. The 2019 gu...
Introduction: Numerous studies worldwide have demonstrated the correlation between different blood lipid indices and the severity of coronary artery disease, as measured by scales such as Gensini and SYNTAX. However, dat...
Objective: Survey on the rate of reaching the LDL-C goal in patients with percutaneous coronary intervention and some risk factors at Huu Nghi hospital Subjects&nbs...
Background: Several studies have investigated the combination treatment of rosuvastatin and ezetimibe in patients with chronic coronary artery disease, but few have focused on an LDL-C cutoff <1,4 mmol/L. Objectives:...
The objective of this study was to characterize blood lipids in individuals with lower extremity arterial disease (LEAD). The cross-sectional descriptive study included individuals with LEAD who were treated at the Vietn...
Objective: Lipid goal attainment in post‐acute coronary syndrome patients undergoing percutaneous coronary intervention and related factors. Subjects and methods: A cross-sectional descriptive study on 4...
Background: Familial hypercholesterolemia (FH) is an autosomal dominant disease caused mainly by mutations in the LDLR gene. Objective: to study the characteristics of dyslipidemia, LDLR gene mutations in 02 pedigrees o...
Introduction: Peripheral artery disease is a chronic disease with long-term progression and risk of disability. Treatment includes surgery and endovascular intervention, the latter is becoming more and more developed. Th...
Introduction: Stroke is one of the leading causes of death and disability worldwide. Carotid endarterectomy for atherosclerotic carotid stenosis has been proved to reduce the incidence of cerebral infarction. Objective:...
The study aimed to determine the SLCO1B1 gene polymorphism in 2 cases of acute rhabdomyolysis related to statin use. This is a case series study of acute rhabdomyolysis associated with statin use and direct sequencing of...
Atherosclerotic cardiovascular disease has become a significant public health concern in Vietnam. To address this issue, prevention strategies should focus on improving the quality of primary care. Family physicians play...
Despite medical advancements, morbidity and mortality rates associated with acute coronary syndrome (ACS) remain high, particularly one year after the acute event. Recent studies have shown that PCSK9 inhibitors therapy...